HLA-C*12:02 is strongly associated with Xuesaitong-induced cutaneous adverse drug reactions.
Yan S, Xiong H, Shao F, Zhang W, Yang F, Qi Z, Chen S, He L, Jiang M, Su Y, Zhu H, Qin S, Zhu Q, Luo X, Xing Q.
Yan S, et al.
Pharmacogenomics J. 2019 Jun;19(3):277-285. doi: 10.1038/s41397-018-0051-3. Epub 2018 Sep 20.
Pharmacogenomics J. 2019.
PMID: 30237582